E3 Green Technology presents energy-saving solutions at CPHI China 2025
Contact Wansheng won the CPHI ESG Responsible Enterprise Award. With its patented technologies such as Bernoulli Laminar Air-curtain Fume Hood, it helps pharmaceutical companies achieve energy conservation and consumption reduction and promotes the green transformation of the industry. The core solutions at the exhibition attracted widespread attention, and technical exchanges deepened the possibility of cooperation.
Winning honors and moving forward, practicing ESG concepts and responsibilities
At this exhibition, E3 Green Technology attracted the attention of many participants with its comprehensive energy-saving solutions in the field of industry laboratories and clean rooms, and successfully won the 2025 CPHI Celebration Awards-ESG Responsible Enterprise Award. This honor is not only a recognition of our work, but also an incentive for us to keep moving forward.
As the "dual carbon" goal continues to advance, the ESG system has become one of the important criteria for measuring the sustainable development capabilities of enterprises. E3 Green Technology has always aimed at energy saving and efficiency improvement and providing an environmentally friendly and healthy environment. Through the continuous research and development of patented products such as Bernoulli Laminar Air-curtain Fume Hood and E·FLOW Damper, it has achieved energy saving and consumption reduction for hundreds of pharmaceutical companies and effectively transformed the ESG concept into technical results.
This award is the industry's encouragement and support for our practice of the ESG concept. We will take this as a starting point, continue to explore in ESG practice, drive the industry's green transformation with technological innovation, and live up to the trust of the industry.
Core solutions empower the industry and explore the forefront of energy-saving technology
E3 Green Technology focused on showcasing two core solutions at the exhibition: laboratory ventilation and air conditioning system safety and energy-saving overall solutions, through innovative products such as Bernoulli Laminar Air-curtain Fume Hood and E·FLOW Damper, combined with variable air volume control systems, successfully overcame industry problems such as disordered airflow organization, high ventilation energy consumption, and insufficient control accuracy in chemical laboratories.
The overall energy-saving solution of the clean room intelligent and precise pressure difference control and air-conditioning system, through intelligent and precise pressure difference control technology and high-efficiency energy-saving air-conditioning system design, can achieve energy saving and consumption reduction while meeting the clean room environmental requirements, and effectively reduce the operating costs for users.
The booth attracted a lot of attention and the atmosphere of technical exchange was strong
At the exhibition, the booth of E3 Green Technology was crowded with people, attracting many colleagues in the industry to stop and visit. The technicians enthusiastically introduced the company's core solutions and innovative products to the visitors in detail, from the operating principles of the laboratory ventilation system to the details of the clean room energy-saving design. There were frequent interactions on site, and the participants had heated discussions on technical difficulties, industry trends and other issues. The in-depth exchanges not only enhanced each other's understanding of the energy-saving needs of the pharmaceutical industry, but also laid the foundation for future cooperation.
The technical exchanges and awards received at the CPHI China 2025 exhibition have added valuable experience to the development of E3 Green Technology . In the future, E3 Green Technology will continue to uphold the spirit of innovation and continue to explore better, more efficient and energy-saving overall solutions, while promoting its own development, and contributing to the green and sustainable development of the global pharmaceutical and related industries.